· 10/17/2001
Lena Gallagher, on Behalf of a Class v. Abbott Laboratories and Miles D. White
Citations
- 269 F.3d 806
- 2001 U.S. App. LEXIS 22409
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- holding that the failure to disclose a compliance letter from the FDA did not render the CEO’s projection of continued growth false or misleading absent evidence that the CEO did not honestly believe in the projection
- explaining that the Form 10-K provides “snapshots” of a registrant’s overall financial position
- explaining that securities laws do not require continuous disclosure
- describing the rule’s application to “registration statements and annual 10-K reports”
- “[F]irms are entitled to keep silent (about good news as well as bad news) unless positive law creates a duty to disclose.”
- \[F]irms are entitled to keep silent (about good news as well as bad news) unless positive law creates a duty to disclose.\
Source: CourtListener parenthetical corpus (CC0).
Judges: Posner, Easterbrook, Kanne
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.